13 years of experience in Industrialization in different type of industries : Spatial, Medical device, Aerospace, Automotive, Electronic Goods domains

LinkedIn : https://www.linkedin.com/in/julien-gillet-daubin-7658ab33/



President & CBO

20 years in the pharmaceutical, medical device and biotechnology industries with numerous deals (ie: 250M$ with GSK); co-founder of Bio Elpida (CMO)

LinkedIn : https://www.linkedin.com/in/gilles-devillers-747752/


Sandrine PEREIRA

Head of R&D

16 years of experience in radiobiology and R&D lab management - (IRSN, AP-HM)

LinkedIn : https://www.linkedin.com/in/sandrine-pereira-ph-d-6619babb/

Last news

Radiosensitivity on a Blood test

Radiosensitivity on a Blood test  July 2017 After intense R&D, Neolys Diagnostics is proud to announce that our R...

BIO2017 – San Diego

BIO2017 – San Diego June 2017 Seeking for sound industrial partners at in North America and Asia, Neolys Diagnostics...

ESTRO 2017 - Vienna

ESTRO 2017 - Vienna May 2017 During the ESTRO (European Society for Radiotherapy and Oncology) Congress in Vienna, Dr ...

All news

Our Technology

Our technology is the result of over ten years of research by the Radiobiology Group. Their work on individual sensitivity have allowed to set up predictive tests. This technology offers a promissing solution, optimizing the efficiency of radiotherapy treatments and preventing toxicity at the same time.

Read more +